News & AnalysisCarlsmed fetches $30m Series BCarlsmed, a creator of spine fusion devices, has secured $30 million in Series B funding.ByIris Dorbian19 April 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs